Supplementary Figure 1 from Phase I Safety, Pharmacokinetic, and Biomarker Study of BIBF 1120, an Oral Triple Tyrosine Kinase Inhibitor in Patients with Advanced Solid Tumors

Isamu Okamoto,Hiroyasu Kaneda,Taroh Satoh,Wataru Okamoto,Masaki Miyazaki,Ryotaro Morinaga,Shinya Ueda,Masaaki Terashima,Asuka Tsuya,Akiko Sarashina,Koichi Konishi,Tokuzo Arao,Kazuto Nishio,Rolf Kaiser,Kazuhiko Nakagawa

openalex（2023）

引用 0|浏览22

暂无评分

关键词

Biomarker Analysis

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要